Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NMRA | AMGN | BMY | GILD | VRTX |
| Company | Neumora Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 2.24 | 259.05 | 56.31 | 90.75 | 401.31 |
| High | 2.59 | 261.19 | 57.03 | 91.53 | 404.74 |
| Low | 2.19 | 257.05 | 55.94 | 90.33 | 399.00 |
| Last | 2.48 | 258.59 | 56.68 | 91.23 | 402.49 |
| Change | +0.31 | -2.63 | +0.11 | -0.18 | -4.62 |
| % Change | +14.29% | -1.01% | +0.19% | -0.20% | -1.13% |
| Volume | 12,582,489 | 4,435,668 | 9,177,155 | 6,756,775 | 1,941,257 |
| 20-Day Average Volume | 4,736,054 | 3,673,411 | 11,193,824 | 6,171,596 | 1,886,439 |
| Previous Close | 2.17 | 261.22 | 56.57 | 91.41 | 407.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.42 | 265.63 | 57.13 | 92.28 | 431.52 |
| 20-Day Raw Stochastic | 6.78% | 17.60% | 34.43% | 37.64% | 24.91% |
| 20-Day Relative Strength | 23.11% | 31.87% | 49.66% | 49.50% | 34.79% |
| Weighted Alpha | -19.99 | -20.46 | +18.53 | +15.26 | -13.17 |
| Today's Opinion | 88% Sell | 88% Sell | 56% Buy | 64% Buy | 88% Sell |
| Previous Opinion | 88% Sell | 88% Sell | 56% Buy | 72% Buy | 72% Sell |
| Last Month's Opinion | 40% Sell | 72% Sell | 100% Buy | 88% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -78.02% since 12/27/24 | -1.77% since 12/27/24 | -1.76% since 12/27/24 | -3.07% since 12/27/24 | -1.55% since 12/27/24 |
| Low | 1.83 on 01/02/25 | 257.05 on 01/06/25 | 55.93 on 12/31/24 | 90.32 on 01/06/25 | 399.00 on 01/06/25 |
| High | 11.51 on 12/30/24 | 263.58 on 01/02/25 | 57.60 on 12/30/24 | 94.00 on 12/30/24 | 411.65 on 01/03/25 |
| 1-Month | |||||
| %Chg | -75.80% since 12/06/24 | -5.35% since 12/06/24 | -4.57% since 12/06/24 | -0.99% since 12/06/24 | -12.92% since 12/06/24 |
| Low | 1.83 on 01/02/25 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 11.57 on 12/27/24 | 280.00 on 12/09/24 | 59.76 on 12/09/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -83.13% since 10/04/24 | -19.29% since 10/04/24 | +5.01% since 10/04/24 | +7.84% since 10/04/24 | -11.62% since 10/04/24 |
| Low | 1.83 on 01/02/25 | 253.30 on 12/19/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 | 377.85 on 12/19/24 |
| High | 17.19 on 10/18/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -75.71% since 07/05/24 | -17.01% since 07/05/24 | +42.88% since 07/05/24 | +36.78% since 07/05/24 | -15.20% since 07/05/24 |
| Low | 1.83 on 01/02/25 | 253.30 on 12/19/24 | 39.50 on 07/08/24 | 66.34 on 07/09/24 | 377.85 on 12/19/24 |
| High | 17.19 on 10/18/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 350,587 | 140,414,384 | 114,733,968 | 113,921,184 | 104,842,624 |
| Shares Outstanding, K | 161,561 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -235,930,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -72,550,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 2.71 | 0.56 | 0.45 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 11/12/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/12/24 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 48.54 | 20.74 | 0.00 |